The combination of miR-320b and miR-141-3p alone or integrated with CA125 and HE4 showed the accurate discrimination capability of early-stage ovarian cancer and healthy controls (AUC 0.79 and 1.00, respectively) [147]. The gene discussed is WFDC2; the disease is ovarian cancer.